Cargando…

A new panel of pancreatic cancer biomarkers discovered using a mass spectrometry-based pipeline

Mostrar otras versiones (1)

BACKGROUND: Pancreatic carcinoma (PC) is an aggressive malignancy that lacks strategies for early detection. This study aimed to develop a coherent, high-throughput and non-discriminatory pipeline for the novel clinical biomarker discovery of PC. METHODS: We combined mass spectrometry (MS)-intensive...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Xiaohui, Zheng, Weimin, Wang, Wansheng, Shen, Huali, Liu, Linxiao, Lou, Wenhui, Wang, Xiaolin, Yang, Pengyuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2017
Materias:	Molecular Diagnostics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5729477/ https://www.ncbi.nlm.nih.gov/pubmed/29123261 http://dx.doi.org/10.1038/bjc.2017.365

Ejemplares similares

A new panel of pancreatic cancer biomarkers discovered using a mass spectrometry-based pipeline
por: Liu, Xiaohui, et al.
Publicado: (2018)

Diagnostic and prognostic role of serum protein peak at 6449 m/z in gastric adenocarcinoma based on mass spectrometry
por: Song, Dongjian, et al.
Publicado: (2016)

Serum microRNA panel as biomarkers for early diagnosis of colorectal adenocarcinoma
por: Zheng, G, et al.
Publicado: (2014)

Investigation of urinary volatile organic metabolites as potential cancer biomarkers by solid-phase microextraction in combination with gas chromatography-mass spectrometry
por: Silva, C L, et al.
Publicado: (2011)

Serum biomarker panels for the diagnosis of gastric adenocarcinoma
por: Ahn, H S, et al.
Publicado: (2012)

Authenticity and drug resistance in a panel of acute lymphoblastic leukaemia cell lines
por: Beesley, A H, et al.
Publicado: (2006)

Analysis of a panel of antibodies to APC reveals consistent activity towards an unidentified protein
por: Davies, M L, et al.
Publicado: (2007)

Prediction of ovarian cancer prognosis and response to chemotherapy by a serum-based multiparametric biomarker panel
por: Oikonomopoulou, K, et al.
Publicado: (2008)

Identification of key clinical phenotypes of breast cancer using a reduced panel of protein biomarkers
por: Green, A R, et al.
Publicado: (2013)

A five-microRNA panel in plasma was identified as potential biomarker for early detection of gastric cancer
por: Zhu, C, et al.
Publicado: (2014)

Issues on fit-for-purpose validation of a panel of ELISAs for application as biomarkers in clinical trials of anti-Angiogenic drugs
por: Brookes, K, et al.
Publicado: (2010)

Evaluation of a new panel of six mononucleotide repeat markers for the detection of DNA mismatch repair-deficient tumours
por: Pagin, A, et al.
Publicado: (2013)

Blockade of SDF-1/CXCR4 signalling inhibits pancreatic cancer progression in vitro via inactivation of canonical Wnt pathway
por: Wang, Z, et al.
Publicado: (2008)

Serum LAMC2 enhances the prognostic value of a multi-parametric panel in non-small cell lung cancer
por: Korbakis, D, et al.
Publicado: (2015)

Poly(A) RT–PCR measurement of diagnostic genes in pancreatic juice in pancreatic cancer
por: Oliveira-Cunha, M, et al.
Publicado: (2011)

MYB is a novel regulator of pancreatic tumour growth and metastasis
por: Srivastava, Sanjeev K, et al.
Publicado: (2015)

miR-367 promotes epithelial-to-mesenchymal transition and invasion of pancreatic ductal adenocarcinoma cells by targeting the Smad7-TGF-β signalling pathway
por: Zhu, Z, et al.
Publicado: (2015)

Interleukin-4 enhances proliferation of human pancreatic cancer cells: evidence for autocrine and paracrine actions
por: Prokopchuk, O, et al.
Publicado: (2005)

Identification of a novel serum biomarker for pancreatic cancer, C4b-binding protein α-chain (C4BPA) by quantitative proteomic analysis using tandem mass tags
por: Sogawa, Kazuyuki, et al.
Publicado: (2016)

Early diagnosis of pancreatic cancer: neutrophil gelatinase-associated lipocalin as a marker of pancreatic intraepithelial neoplasia
por: Moniaux, N, et al.
Publicado: (2008)

KIF15 promotes pancreatic cancer proliferation via the MEK–ERK signalling pathway
por: Wang, Jie, et al.
Publicado: (2017)

Prediction of outcome of early ER+ breast cancer is improved using a biomarker panel, which includes Ki-67 and p53
por: Millar, E K A, et al.
Publicado: (2011)

S100A6 binds to annexin 2 in pancreatic cancer cells and promotes pancreatic cancer cell motility
por: Nedjadi, T, et al.
Publicado: (2009)

A four-kallikrein panel for the prediction of repeat prostate biopsy: data from the European Randomized Study of Prostate Cancer Screening in Rotterdam, Netherlands
por: Gupta, A, et al.
Publicado: (2010)

A combined biomarker panel shows improved sensitivity for the early detection of ovarian cancer allowing the identification of the most aggressive type II tumours
por: Russell, Matthew R, et al.
Publicado: (2017)

Endostatin expression in pancreatic tissue is modulated by elastase
por: Brammer, R D, et al.
Publicado: (2005)

Overexpression of neuropilin-1 promotes constitutive MAPK signalling and chemoresistance in pancreatic cancer cells
por: Wey, J S, et al.
Publicado: (2005)

Inhibition of endogenous SPARC enhances pancreatic cancer cell growth: modulation by FGFR1-III isoform expression
por: Chen, G, et al.
Publicado: (2010)

Clinical significance of midkine expression in pancreatic head carcinoma
por: Maeda, S, et al.
Publicado: (2007)

Desmogleins as prognostic biomarkers in resected pancreatic ductal adenocarcinoma
por: Ormanns, Steffen, et al.
Publicado: (2015)

Meta-analysis of immunohistochemical prognostic markers in resected pancreatic cancer
por: Smith, R A, et al.
Publicado: (2011)

Tumour epithelial vimentin expression and outcome of pancreatic ductal adenocarcinomas
por: Handra-Luca, A, et al.
Publicado: (2011)

Discovery of serum biomarkers for pancreatic adenocarcinoma using proteomic analysis
por: Xue, A, et al.
Publicado: (2010)

Immune cell infiltration as an indicator of the immune microenvironment of pancreatic cancer
por: Ino, Y, et al.
Publicado: (2013)

Clinical impact of pentraxin family expression on prognosis of pancreatic carcinoma
por: Kondo, S, et al.
Publicado: (2013)

Polypeptide N-acetylgalactosaminyltransferase 6 expression in pancreatic cancer is an independent prognostic factor indicating better overall survival
por: Li, Z, et al.
Publicado: (2011)

MicroRNA-345 induces apoptosis in pancreatic cancer cells through potentiation of caspase-dependent and -independent pathways
por: Srivastava, Sanjeev K, et al.
Publicado: (2015)

High expression of TROP2 correlates with poor prognosis in pancreatic cancer
por: Fong, D, et al.
Publicado: (2008)

Pancreatic cancer cells resistance to gemcitabine: the role of MUC4 mucin
por: Bafna, S, et al.
Publicado: (2009)

Considerations for the use of plasma cytokeratin 18 as a biomarker in pancreatic cancer
por: Dive, C, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_30r7nl7lkvsfmttuvv7abt158v